Age-related hepatitis B seroconversion rates in health care workers

被引:18
作者
Havlichek, D
Rosenman, K
Simms, M
Guss, P
机构
[1] Departments of Medicine, College of Human Medicine, Michigan State University
[2] Occupational Health Service, Michigan State University
[3] Microbiology and Public Health, Michigan State University
[4] Department of Medicine, B-320 Life Sciences Bldg., E. Lansing
关键词
D O I
10.1016/S0196-6553(97)90090-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Protective hepatitis titers are reported for more than 90% of healthy adults who received three intradeltoid injections of vaccine. Some factors that influence seroconversion rates include age, sex, and presence of chronic diseases. Methods: Because of work-related factors that placed them at risk of acquiring hepatitis B, 112 employees, who ranged in age from 20 to 70 years with a mean age of 39.2 years, completed the hepatitis B vaccination series between 1986 and 1993. All participants received three vaccinations. Results: Hepatitis B surface antibody did not develop in 16 of 112 recipients (14.2%, 95% CI, 7.6% to 20.8%). Race, sex, and duration to antibody titer did not affect rates of seroconversion. Age greater than 50 years was associated with significantly decreased seroconversion rates (64.7%, 95% CI, 42.0% to 87.4%) compared with seroconversion rates of those younger than 50 years of age (89.5%, 95% CI 83.3% to 95.7%, p = 0.02). Conclusions: Our results indicate that it-hen a hepatitis B immunization program is implemented, seroconversion rates are lower than published rates for healthy adults and adolescents. We recommend that seroconversion data from immunization programs for employees at risk for hepatitis B be reviewed and that postimmunization testing be considered to ensure adequate protection for those employees at highest risk for nonconversion.
引用
收藏
页码:418 / 420
页数:3
相关论文
共 7 条
[1]  
*AM COLL PHYS TASK, 1994, GUID AD IMM, P74
[2]   HEPATITIS-B VACCINATION IN THE ELDERLY [J].
DENIS, F ;
MOUNIER, M ;
HESSEL, L ;
MICHEL, JP ;
GUALDE, N ;
DUBOIS, F ;
BARIN, F ;
GOUDEAU, A .
JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (06) :1019-1019
[3]  
JILG W, 1984, LANCET, V2, P1174
[4]  
*MED EC DAT PROD C, 1997, PHYS DESK REF, P1787
[5]   HEPATITIS-B VACCINE RESPONSIVENESS IN CONNECTICUT PUBLIC SAFETY PERSONNEL [J].
ROOME, AJ ;
WALSH, SJ ;
CARTTER, ML ;
HADLER, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (24) :2931-2934
[6]   RISK-FACTORS FOR LACK OF DETECTABLE ANTIBODY FOLLOWING HEPATITIS-B VACCINATION OF MINNESOTA HEALTH-CARE WORKERS [J].
WOOD, RC ;
MACDONALD, KL ;
WHITE, KE ;
HEDBERG, CW ;
HANSON, M ;
OSTERHOLM, MT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (24) :2935-2939
[7]  
1991, FED REGISTER, V56, P64004